Evidence map›Paper›PMID 41612413›Full record

ArticleInfectious agents and cancer2026

Bacterial vaginosis in microscopic examination of Pap smears in patients with high-risk HPV is associated with viral persistence and cytological progression in a longitudinal study.

Lara Linz, Nina Zachau, Sibylle Spieth, Patrick Finzer

Abstract read
In one paragraph

Article in Infectious agents and cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lara LinzInstitut fuer Medizinische Mikrobiologie und Krankenhaushygiene, Universitaetsklinikum Duesseldorf, Heinrich-Heine Universitaet Duesseldorf, Duesseldorf, Germany.
Nina ZachauCBT Bonn, Zytologie und Pathologie, Bonn, Germany.
Sibylle SpiethCBT Bonn, Zytologie und Pathologie, Bonn, Germany.
Patrick FinzerInstitut fuer Medizinische Mikrobiologie und Krankenhaushygiene, Universitaetsklinikum Duesseldorf, Heinrich-Heine Universitaet Duesseldorf, Duesseldorf, Germany. patrick.finzer@uni-duesseldorf.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe vaginal microbiome is increasingly studied using sequencing approaches; however, the exact bacterial community structure in vaginal diseases, e.g. bacterial vaginosis (BV), remains unclear. Vaginal Pap smears routinely obtained in preventive screening programs can also be evaluated with high accuracy regarding microbial colonization by means of microscopy.

methodsThis longitudinal retrospective case control study aims to investigate the relationship between microscopic vaginal flora observed in Pap-smears and Human Papilloma Virus (HPV) clearance, persistence or progression using HPV-PCR tests and the results of the Pap-smears. Two cohorts of high-risk HPV positive patients were formed. Cohort A (n = 136) was observed over a two-year time period 2020–2022, while cohort B (n = 160) was observed over a one-year period from 2021 to 2022. Each case group consisted of BV-positive patients that were compared to BV negative patients as controls.

resultsIt was found that the case groups in both cohorts had a higher HPV persistence rate and a higher rate of progression at follow-up. Lactobacillus flora was consistently associated with favorable outcomes, particularly higher HPV clearance rates across both cohorts and the entire observation period. In contrast patients with bacterial vaginosis (BV) were associated with significantly increased risk of HPV progression, especially in Cohort B, supporting its role as risk factor in the development of precancerous cervical lesions.

conclusionThe integration of microscopic flora assessment into screening programs for cervical cancer may help to improve risk stratification in HPV positive women. Our findings suggest that, BV-positive patients may benefit from a closer follow-up period and earlier therapeutic intervention. CLINIAL TRIAL NUMBER: Not applicable.

Indexed as

Bacterial vaginosisCytological progressionHigh-risk HPVHPV-persistencePap smears

Identifiers

PMID41612413
PMCPMC12895659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.